![Maxine Gowen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maxine Gowen
Président chez
PASSAGE BIO, INC.
Fortune : 151 670 $ au 31/05/2026
Profil
Maxine Gowen was the founder of Trevena, Inc., founded in 2007, and served as Director from 2018 to 2021.
Current jobs include Chairman at Passage Bio, Inc. since 2022, Director at Conforma Therapeutics Corp., Independent Director at Aclaris Therapeutics, Inc. since 2019, and Director at TamuroBio, Inc. since 2021.
Former jobs include Independent Director at Human Genome Sciences, Inc. from 2011 to 2012; Director roles at Morphotek, Inc., Santarus, Inc., and Azelon Pharmaceuticals, Inc.; Director at Biotechnology Innovation Organization from 2008 to 2018; Independent Director at Akebia Therapeutics, Inc. from 2014 to 2021; Director at Panorama Medicine, Inc. from 2020 to 2021; Independent Director at Aceragen, Inc. from 2016 to 2023; Independent Director at Idera Pharmaceuticals, Inc. from 2016 to 2022; Director at Life Sciences Pennsylvania from 2016 to 2021; Independent Non-Executive Director at Merus NV from 2021 to 2025; President & Managing Partner at GSK Equity Investments Ltd. from 2002 to 2005; SVP-External Drug Discovery Excellence Center at GSK Plc from 2005 to 2007; VP-Drug Discovery & Musculoskeletal Diseases at GSK Plc from 1992 to 2002; Head-Bone Cell Biology Group at the University of Bath from 1989 to 1992; and Senior Vice President at Center of Excellence For External Drug Discovery.
Education includes a doctorate from the University of Bath, an undergraduate degree from the University of Bristol in 1979, a doctorate from The University of Sheffield in 1984, and an MBA from The Wharton School of the University of Pennsylvania in 2002.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2026 | 33 334 ( 0,02 % ) | 151 670 $ | 31/05/2026 | |
PASSAGE BIO, INC. -.--% | 19/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Maxine Gowen
| Sociétés | Poste | Début |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 02/07/2019 |
| PASSAGE BIO, INC. | Président | 31/08/2021 |
TamuroBio, Inc.
 TamuroBio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Directeur/Membre du Conseil | 01/08/2019 |
Conforma Therapeutics Corp.
 Conforma Therapeutics Corp. BiotechnologyHealth Technology Designs and develops drugs for treatment of cancer | Directeur/Membre du Conseil | - |
Anciens postes connus de Maxine Gowen
| Sociétés | Poste | Fin |
|---|---|---|
| MERUS N.V. | Directeur/Membre du Conseil | 29/12/2025 |
| ACERAGEN, INC. | Directeur/Membre du Conseil | 15/08/2023 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Directeur/Membre du Conseil | 01/01/2022 |
| AKEBIA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 06/06/2021 |
| TREVENA, INC. | Fondateur | 01/05/2021 |
Formation de Maxine Gowen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
23
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 23 |
|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Morphotek, Inc.
 Morphotek, Inc. BiotechnologyHealth Technology Develops oncology therapies | Health Technology |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Engages in acquiring, developing and commercializing pharmaceutical products for the treatment of upper & lower gastrointestinal diseases and disorders | Health Technology |
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs for the treatment of osteoporosis | Health Technology |
Conforma Therapeutics Corp.
Conforma Therapeutics Corp. BiotechnologyHealth Technology Designs and develops drugs for treatment of cancer | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Bath
 University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sheffield
 The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Provides consulting services to biosciences industry | Commercial Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Trevena, Inc.
 Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Panorama Medicine, Inc.
 Panorama Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an drug discovery platform that integrates genomics, big data and computing to find drugs that can treat diseases caused by errors during RNA processing | Commercial Services |
Center of Excellence For External Drug Discovery | |
TamuroBio, Inc.
TamuroBio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Aceragen, Inc.
 Aceragen, Inc. BiotechnologyHealth Technology Discovers, develops, and commercializes therapeutics for oncology and rare diseases | Health Technology |
